Award recordCONTRACT

GRIFOLS THERAPEUTICS LLC

PIID VA26214F7024· VHA· 262-NETWORK CONTRACT OFFICE 22· 6505 · DRUGS AND BIOLOGICALS· FY2014· $144,000 net obligations· UEI UFQ3A7GKJ5C7· NC

Description

PHARMACEUTICAL DRUGS: PROLASTIN VIALS

First action · last action
2014-09-24 · 2014-10-01
Transactions
3
First transaction's obligation
$0
Base + all options value (sum of deltas)
$144,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30042
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$144,000$0Base award · 2014-09-24 · this action $0 · running total $0Modification P00001 · 2014-10-01 · this action $144,000 · running total $144,000Modification P00002 · 2014-10-01 · this action $0 · running total $144,000
  • Base2014-09-24+$0= $0
  • Mod P000012014-10-01+$144,000= $144,000
  • Mod P000022014-10-01+$0= $144,000
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-09-24+$0$0PHARMACEUTICAL DRUGS: PROLASTIN VIALS
Mod P00001· FUNDING ONLY ACTION2014-10-01+$144,000$144,000PHARMACEUTICAL DRUGS: PROLASTIN VIALS
Mod P00002· CHANGE ORDER2014-10-01+$0$144,000PHARMACEUTICAL DRUGS: PROLASTIN VIALS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI UFQ3A7GKJ5C7)

AwardOffice · PSC / listingNet obligationsFY
36C26022F0140260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$100,282FY2022
36C26022F0004260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$454,461FY2022
36C26021F0264260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$130,406FY2021
36C26021F0117260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$75,000FY2021
36C26021F0014260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$220,000FY2021
36C26021F0021260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$355,273FY2021

Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26216J3405SANOFI VACCINES US INC.262-NETWORK CONTRACT OFFICE 22$209,679FY2016
VA26216P3483JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC.262-NETWORK CONTRACT OFFICE 22$14,960FY2016
VA26216E3967MCKESSON CORPORATION262-NETWORK CONTRACT OFFICE 22$20,913,958FY2016
VA26216P2987PETNET SOLUTIONS, INC.262-NETWORK CONTRACT OFFICE 22$58,136FY2016
VA26216E3446MCKESSON CORPORATION262-NETWORK CONTRACT OFFICE 22$11,612,703FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26214F7024_3600_V797D30042_3600 · retrieved 2026-09-26.